The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

 
Web www.patentalert.com

< Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist

< Novel compounds

> Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases

> Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function
~ 00201